STOCK TITAN

IMAX Financials

IMAX NYSE
Trailing 12 months to September 30, 2026
Revenue $484.0M +28.1% YoY
Net Income $134.1M +239.0% YoY
EPS (Diluted) $2.31 +230.0% YoY
Free Cash Flow $146.0M +49.2% YoY
Market Cap $2.6B as of Nov 17, 2026
Price / Sales 5.4x on $484.0M revenue, trailing 12 months to September 30, 2026
Price / Earnings 19.4x on $134.1M net income, trailing 12 months to September 30, 2026
Price / Book 5.3x on $491.5M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 17, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Nov 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the IMAX SEC filings page.

Imax Corp (IMAX) reported $484.0M in revenue over the twelve months to Sep 30, 2026, up 28.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI IMAX FY2025

IMAX's 2025 rebound converted modest revenue growth into outsized operating profit and cash generation without a matching capital-spending surge.

From FY2023 to FY2025, revenue increased 9.4% while operating income rose 67.1%, indicating that margin structure and cost absorption, not volume alone, drove the improvement. Cash conversion strengthened alongside profitability: free-cash-flow margin expanded 15.1 percentage points over that span while FY2025 capital expenditures were just 2.0% of revenue.

FY2025 revenue reached $410M as gross margin climbed to 60.0%; that widening spread suggests the year's profit acceleration was not merely a volume effect. SG&A was 33.8% of revenue, down from 37.7% in FY2024, reinforcing that operating costs consumed less of each sales dollar.

Operating cash flow was $127M versus net income of $35M, so cash generation materially exceeded reported earnings. Free cash flow reached $119M while capex was $8M, and liabilities were 52.2% of assets versus 54.5% in FY2024, pairing limited reinvestment with a less liability-heavy balance sheet.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 57 / 100
Financial Health Score (4 of 6 dimensions) 57/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 4 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Imax Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
67

Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. Imax Corp scores 67/100 on it among other operating companies.

Growth
47

Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. Imax Corp scores 47/100 on it among other operating companies.

Leverage
25

Imax Corp carried $1.38 of total liabilities for every $1 of shareholders' equity at the end of fiscal year 2025. With no long-term debt figure for fiscal year 2025, Imax Corp is ranked on that ratio rather than on net debt against EBITDA, a lower ratio being the safer one, and scores 25/100 among other operating companies measured the same way.

Liquidity
n/a

Not available for Imax Corp, so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.

Cash Flow
89

Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. Imax Corp scores 89/100 on it among other operating companies.

Returns
n/a

Not available for Imax Corp, so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.

Piotroski F-Score Partial
6/7

Imax Corp passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Cash-Backed
3.64x

For every $1 of reported earnings, Imax Corp generates $3.64 in operating cash flow ($127.1M OCF vs $34.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
11.44x

Imax Corp earns $11.44 in operating income for every $1 of interest expense ($84.2M vs $7.4M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$174.6M
YoY+63.7%
QoQ+69.7%
5Y CAGR+25.3%
10Y CAGR+7.3%

Imax Corp generated $174.6M in revenue in Q3 2026. This represents an increase of 63.7% from the same quarter a year earlier. Against the prior quarter it is up 69.7%.

EBITDA
$101.7M
YoY+127.8%
QoQ+179.0%
5Y CAGR+48.6%

Imax Corp's EBITDA was $101.7M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 127.8% from the same quarter a year earlier. Against the prior quarter it is up 179.0%.

Net Income
$113.8M
YoY+450.9%
QoQ+638.9%
5Y CAGRn/m
10Y CAGR+46.3%

Imax Corp reported $113.8M in net income in Q3 2026. This represents an increase of 450.9% from the same quarter a year earlier. Against the prior quarter it is up 638.9%.

EPS (Diluted)
$1.96
YoY+429.7%
QoQ+625.9%
5Y CAGRn/m
10Y CAGR+47.6%

Imax Corp earned $1.96 per diluted share (EPS) in Q3 2026. This represents an increase of 429.7% from the same quarter a year earlier. Against the prior quarter it is up 625.9%.

Cash & Balance Sheet

Free Cash Flow
$84.2M
YoY+29.9%
QoQ+163.3%
5Y CAGRn/m

Imax Corp generated $84.2M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 29.9% from the same quarter a year earlier. Against the prior quarter it is up 163.3%.

Cash & Debt
$207.9M
YoY+45.3%
QoQ+30.0%
5Y CAGR+1.5%
10Y CAGR-0.5%

Imax Corp held $207.9M in cash as of Q3 2026; no long-term debt figure is on record for that period.

Shares Outstanding
55M
YoY+2.6%
QoQ+0.7%
5Y CAGR-1.3%
10Y CAGR-1.9%

Imax Corp had 55M shares outstanding in Q3 2026. This represents an increase of 2.6% from the same quarter a year earlier. Against the prior quarter it is up 0.7%.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin
72.4%
YoY+9.3pp
QoQ+11.2pp
5Y change+23.8pp
10Y change+20.5pp

Imax Corp's gross margin was 72.4% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 9.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 11.2 percentage points.

Operating Margin
42.9%
YoY+15.7pp
QoQ+22.7pp
5Y change+44.4pp

Imax Corp's operating margin was 42.9% in Q3 2026, reflecting core business profitability. This is up 15.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 22.7 percentage points.

Net Margin
65.2%
YoY+45.8pp
QoQ+50.2pp
5Y change+80.0pp
10Y change+62.3pp

Imax Corp's net profit margin was 65.2% in Q3 2026, showing the share of revenue converted to profit. This is up 45.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 50.2 percentage points.

Return on Equity
23.2%
YoY+17.2pp
QoQ+18.8pp
5Y change+25.6pp
10Y change+22.7pp

Imax Corp's quarterly ROE was 23.2% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 17.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 18.8 percentage points.

Capital Allocation

R&D Spending
$1.9M
YoY+26.2%
QoQ+14.8%

Imax Corp invested $1.9M in research and development in Q3 2026. This represents an increase of 26.2% from the same quarter a year earlier. Against the prior quarter it is up 14.8%.

Capital Expenditures
$1.9M
YoY-29.2%
QoQ+9147.6%
5Y CAGR+14.5%

Imax Corp invested $1.9M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 29.2% from the same quarter a year earlier. Against the prior quarter it is up 9147.6%.

Share Buybacks

Not reported for Q3 2026.

IMAX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IMAX quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$174.6M+63.7%$102.8M+12.2%$81.4M-6.1%$125.2M+35.1%$106.7M+16.6%$91.7M+3.1%$86.7M+9.5%$92.7M+7.7%
Cost of Revenue$48.3M+22.5%$39.9M+4.9%$35.6M+6.2%$53.1M+19.8%$39.4M-2.6%$38.1M-15.4%$33.5M+3.9%$44.3M+4.7%
Gross Profit$126.3M+87.8%$62.9M+17.3%$45.8M-13.9%$72.1M+49.2%$67.3M+31.9%$53.6M+22.0%$53.2M+13.4%$48.4M+10.7%
R&D Expenses$1.9M+26.2%$1.7M+7.3%$1.8M+36.9%$1.5M+26.2%$1.5M$1.5M-24.1%$1.3M-39.7%$1.1M-57.8%
SG&A Expenses$39.1M+14.2%$34.5M-2.2%$32.5M-2.9%$35.5M+9.4%$34.2M+8.7%$35.3M-6.0%$33.5M+7.1%$32.4M-7.6%
Operating Income$74.9M+157.8%$20.8M+44.8%$10.0M-40.5%$24.1M+153.4%$29.0M+49.6%$14.3M+399.5%$16.7M+38.7%$9.5M+247.3%
EBITDA$101.7M+127.8%$36.4M+20.5%$25.2M-20.4%$40.1M+53.7%$44.7M+30.1%$30.2M+39.3%$31.6M+16.2%$26.1M+60.4%
Interest Expense$1.8M-3.2%$2.0M+1.8%$1.9M+5.3%$1.8M+11.4%$1.8M-18.2%$1.9M-15.6%$1.8M-7.4%$1.6M-9.0%
Income Tax-$43.3M-931.9%$3.5M+192.7%$2.4M-66.8%$4.1M+179.8%$5.2M+119.1%$1.2Mn/m$7.3M+41.2%$1.5Mn/m
Net Income$113.8M+450.9%$15.4M+36.8%$4.2M+81.6%$637K-88.0%$20.7M+48.7%$11.3M+214.1%$2.3M-28.9%$5.3M+108.9%
EPS (Basic)$2.07+444.7%$0.28+33.3%$0.08+100.0%$0.01-90.0%$0.38+46.2%$0.21+200.0%$0.04-33.3%$0.10+100.0%
EPS (Diluted)$1.96+429.7%$0.27+35.0%$0.07+75.0%$0.01-88.9%$0.37+42.3%$0.20+185.7%$0.04-33.3%$0.09+80.0%
Diluted Shares (Avg)58M+4.4%57M+2.6%56M+2.6%N/A56M+2.7%55M+3.2%55M+2.9%N/A

IMAX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IMAX quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'25FilingQ4'2410-K
Total Assets$1.0B+15.8%$917.9M+5.7%$893.2M+5.3%$894.0M+7.7%$889.6M+5.0%$868.6M+5.0%$848.3M+2.9%$830.4M+1.9%
Cash & Equivalents$207.9M+45.3%$159.9M+46.4%$146.0M+50.4%$151.2M+50.3%$143.1M+36.9%$109.3M+19.3%$97.1M+19.8%$100.6M+32.0%
Inventory$45.2M+9.1%$39.2M+6.9%$35.8M+12.9%$32.5M-1.0%$41.4M+10.2%$36.7M-2.9%$31.7M-12.2%$32.8M+4.0%
Accounts Receivable$139.0M+28.2%$114.6M-9.8%$108.5M-11.3%$108.1M+0.4%$108.4M-5.1%$126.9M+4.5%$122.3M-13.0%$107.7M-21.0%
Goodwill$39.0M-26.1%$45.8M-13.3%$45.8M-13.3%$45.8M-13.3%$52.8M0.0%$52.8M0.0%$52.8M0.0%$52.8M0.0%
Total Liabilities$439.8M-2.9%$467.5M+0.9%$464.8M+0.2%$466.3M+3.1%$452.9M-5.6%$463.5M-4.3%$464.0M-5.4%$452.2M-3.6%
Total Equity$491.5M+40.6%$355.9M+11.1%$335.5M+12.0%$337.9M+12.8%$349.5M+20.8%$320.4M+19.9%$299.5M+15.7%$299.5M+9.6%
Retained Earnings-$117.0Mn/m-$230.8Mn/m-$235.7Mn/m-$240.0Mn/m-$240.6Mn/m-$261.3Mn/m-$272.4Mn/m-$274.7Mn/m

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Long-Term Investments, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

IMAX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IMAX quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$86.1M+27.5%$32.0M+37.7%$4.0M-42.0%$29.4M+155.8%$67.5M+91.4%$23.2M-33.7%$7.0Mn/m$11.5M+186.6%
Depreciation & Amortization$26.8M+71.9%$15.7M-1.4%$15.2M+2.2%$16.0M-3.4%$15.6M+4.7%$15.9M-15.6%$14.9M-1.7%$16.6M+22.6%
Stock-Based Compensation$9.8M+55.6%$7.3M-1.4%$5.7M+9.6%N/A$6.3M+16.7%$7.4M+7.2%$5.2M+10.6%N/A
Capital Expenditures$1.9M-29.2%$21K-99.1%$2.1M+29.6%$1.4M-69.3%$2.7M+143.7%$2.4M+48.9%$1.6M+49.0%$4.6M+16.8%
Free Cash Flow$84.2M+29.9%$32.0M+53.2%$1.9M-64.2%$28.0M+306.8%$64.8M+89.6%$20.9M-37.6%$5.3Mn/m$6.9M+11957.9%
Investing Cash Flow-$8.7Mn/m-$6.1Mn/m-$6.9Mn/m-$7.1Mn/m-$12.7Mn/m-$7.4Mn/m-$14.6Mn/m-$10.9Mn/m
Financing Cash Flow-$29.8Mn/m-$11.5Mn/m-$2.8M-165.2%-$13.7Mn/m-$20.9Mn/m-$3.8Mn/m$4.2M-81.4%-$5.1Mn/m
Share BuybacksN/AN/AN/AN/AN/AN/A$0-100.0%N/A

Not reported in any period shown, so not listed: Dividends Paid.

IMAX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IMAX quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Gross Margin72.4%+9.3pp61.2%+2.7pp56.3%-5.1pp57.6%+5.4pp63.1%+7.3pp58.5%+9.1pp61.4%+2.1pp52.2%+1.4pp
Operating Margin42.9%+15.7pp20.2%+4.6pp12.2%-7.1pp19.3%+9.0pp27.2%+6.0pp15.7%+12.4pp19.3%+4.1pp10.3%+7.1pp
Net Margin65.2%+45.8pp15.0%+2.7pp5.2%+2.5pp0.5%-5.2pp19.4%+4.2pp12.3%+8.3pp2.7%-1.5pp5.7%+2.8pp
Return on Equity23.2%+17.2pp4.3%+0.8pp1.3%+0.5pp0.2%-1.6pp5.9%+1.1pp3.5%+2.2pp0.8%-0.5pp1.8%+0.8pp
Return on Assets11.1%+8.7pp1.7%+0.4pp0.5%+0.2pp0.1%-0.6pp2.3%+0.7pp1.3%+0.9pp0.3%-0.1pp0.6%+0.3pp
Liabilities-to-Equity0.89-0.4x1.31-0.1x1.39-0.2x1.38-0.1x1.30-0.4x1.45-0.4x1.55-0.3x1.51-0.2x
Asset Turnover0.170.0x0.110.0x0.090.0x0.140.0x0.120.0x0.110.0x0.100.0x0.110.0x
FCF Margin48.2%-12.5pp31.1%+8.3pp2.3%-3.8pp22.3%+14.9pp60.7%+23.4pp22.8%-14.8pp6.1%+21.4pp7.4%+7.3pp

Not reported in any period shown, so not listed: Current Ratio, Debt-to-Equity.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Imax Corp IMAX FY2025 $410.2M $34.9M 8.5% $2.6B 57/100
AMC Entertainment Holdings, Inc. AMC FY2025 $4.8B -$632.4M -13.0% $2.8B 19/100
Madison Square Garden Entertainment Corp. MSGE FY2026 $1.1B $66.2M 6.2% $3.8B 49/100
Atlanta Braves Holdings, Inc. BATRK FY2025 $732.5M -$23.4M -3.2% $3.3B 26/100
Cinemark Holdings, Inc. CNK FY2025 $3.1B $138.2M 4.4% $4.7B 29/100
Manchester United plc MANU FY2026 $898.5M -$57.0M -6.3% $3.7B 28/100

Frequently Asked Questions

Imax Corp (IMAX) reported $410.2M in total revenue for fiscal year 2025. This represents a 16.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Imax Corp (IMAX) revenue grew by 16.5% year-over-year, from $352.2M to $410.2M in fiscal year 2025.

Yes, Imax Corp (IMAX) reported a net income of $134.1M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $34.9M, with a net profit margin of 8.5%.

Imax Corp (IMAX) reported diluted earnings per share of $0.63 for fiscal year 2025. This represents a 31.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Imax Corp (IMAX) had EBITDA of $146.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Imax Corp (IMAX) had a gross margin of 60.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Imax Corp (IMAX) had an operating margin of 20.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Imax Corp (IMAX) had a net profit margin of 8.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Imax Corp (IMAX) has a return on equity of 10.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Imax Corp (IMAX) generated $118.9M in free cash flow during fiscal year 2025. This represents a 90.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Imax Corp (IMAX) generated $127.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Imax Corp (IMAX) had $894.0M in total assets as of fiscal year 2025, including both current and long-term assets.

Imax Corp (IMAX) invested $8.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Imax Corp (IMAX) invested $5.8M in research and development during fiscal year 2025.

Imax Corp (IMAX) had 54M shares outstanding as of fiscal year 2025.

Imax Corp (IMAX) had a liabilities-to-equity ratio of 1.38 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

Imax Corp (IMAX) had a return on assets of 3.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Imax Corp (IMAX) trades at 19.4x earnings, its market capitalization divided by $134.1M net income, trailing 12 months to September 30, 2026. The market capitalization is $2.6B as of Nov 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Imax Corp (IMAX) trades at 5.4x sales, its market capitalization divided by $484.0M revenue, trailing 12 months to September 30, 2026. The market capitalization is $2.6B as of Nov 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Imax Corp (IMAX) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Imax Corp (IMAX) has an earnings quality ratio of 3.64x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Imax Corp (IMAX) has an interest coverage ratio of 11.44x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Imax Corp (IMAX) scores 57 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For Imax Corp it averages the 4 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top